Investor Information

 

Theralase® Inc. is a subsidiary of Theralase® Technologies Inc., and is publicly traded on the 

  • TSX Venture Exchange (TLT-TSXV) and the
  • OTCQB (TLTFF)

Data last updated on March 14, 2020


 

Number of common shares outstanding

Basic: 204,275,375

Warrants: 91,814,705

Options: 16,920,000 

Fully Diluted: 313,010,080

Insider Ownership: 7% (9.3% fully diluted)

[stockdio-historical-chart]

Financial Filings

 
Downloaded 317 times.
Downloaded 305 times.
Downloaded 284 times.
Downloaded 268 times.
Downloaded 509 times.
Downloaded 334 times.
Downloaded 268 times.
Downloaded 265 times.
Downloaded 173 times.
Downloaded 103 times.
Downloaded 265 times.
Downloaded 55 times.
Downloaded 10 times.
Downloaded 9 times.
Downloaded 13 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 3 times.
Downloaded 5 times.
Downloaded 1 times.
Downloaded 0 times.
Downloaded 2 times.
Downloaded 2 times.
Downloaded 2 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 1 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 7 times.
 
Downloaded 18 times.
Downloaded 207 times.
Downloaded 189 times.
Downloaded 183 times.
Downloaded 284 times.
Downloaded 181 times.
Downloaded 181 times.
Downloaded 183 times.
Downloaded 122 times.
Downloaded 79 times.
Downloaded 46 times.
Downloaded 38 times.
Downloaded 4 times.
Downloaded 6 times.
Downloaded 10 times.
Downloaded 0 times.
Downloaded 4 times.
Downloaded 0 times.
Downloaded 5 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 1 times.
Downloaded 3 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 7 times.
SEDAR Filings (System for Electronic Document Analysis and Retrieval)

Theralase's complete public securities documents are available in English and French on SEDAR.